Taber JM - Search Results

1

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Aspinwall LG, Stump TK, Taber JM, Drummond DM, Kohlmann W, Champine M, Leachman SA. Aspinwall LG, et al. Among authors: taber jm. Transl Behav Med. 2018 Jan 29;8(1):29-43. doi: 10.1093/tbm/ibx011. Transl Behav Med. 2018. PMID: 29385581 Free PMC article.

2

Testing Explanations for Skepticism of Personalized Risk Information.

Waters EA, Taber JM, Ackermann N, Maki J, McQueen AM, Scherer LD. Waters EA, et al. Among authors: taber jm. Med Decis Making. 2023 May;43(4):430-444. doi: 10.1177/0272989X231162824. Epub 2023 Apr 2. Med Decis Making. 2023. PMID: 37005827 Free PMC article.

3

Number lines can be more effective at facilitating adults' performance on health-related ratio problems than risk ladders and icon arrays.

Mielicki MK, Fitzsimmons CJ, Schiller LK, Scheibe D, Taber JM, Sidney PG, Matthews PG, Waters EA, Coifman KG, Thompson CA. Mielicki MK, et al. Among authors: taber jm. J Exp Psychol Appl. 2023 Sep;29(3):529-543. doi: 10.1037/xap0000456. Epub 2022 Nov 3. J Exp Psychol Appl. 2023. PMID: 36326639

4

Parental preferences for CDKN2A/p16 testing of minors.

Taber JM, Aspinwall LG, Kohlmann W, Dow R, Leachman SA. Taber JM, et al. Genet Med. 2010 Dec;12(12):823-38. doi: 10.1097/GIM.0b013e3181f87278. Genet Med. 2010. PMID: 21045708 Free article.

5

Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.

Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA. Aspinwall LG, et al. Among authors: taber jm. Psychooncology. 2013 Feb;22(2):276-89. doi: 10.1002/pon.2080. Epub 2011 Oct 7. Psychooncology. 2013. PMID: 23382133

6

Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.

Aspinwall LG, Taber JM, Leaf SL, Kohlmann W, Leachman SA. Aspinwall LG, et al. Among authors: taber jm. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1687-97. doi: 10.1158/1055-9965.EPI-13-0422. Epub 2013 Aug 15. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23950214 Free PMC article.

7

Partner involvement in conduct of skin self-examinations remains low following CDKN2A/p16 genetic test reporting and counseling.

Taber JM, Aspinwall LG, Leaf SL, Kohlmann W, Leachman SA. Taber JM, et al. J Am Acad Dermatol. 2013 Nov;69(5):842-844. doi: 10.1016/j.jaad.2013.06.048. J Am Acad Dermatol. 2013. PMID: 24124830 No abstract available.

8

Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.

Aspinwall LG, Taber JM, Kohlmann W, Leaf SL, Leachman SA. Aspinwall LG, et al. Among authors: taber jm. J Genet Couns. 2014 Jun;23(3):421-37. doi: 10.1007/s10897-013-9676-1. Epub 2013 Dec 10. J Genet Couns. 2014. PMID: 24322567 Free PMC article.

9

Preferences for blood-based colon cancer screening differ by race/ethnicity.

Taber JM, Aspinwall LG, Heichman KA, Kinney AY. Taber JM, et al. Am J Health Behav. 2014 May;38(3):351-61. doi: 10.5993/AJHB.38.3.4. Am J Health Behav. 2014. PMID: 24636031

10

Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.

Aspinwall LG, Taber JM, Kohlmann W, Leaf SL, Leachman SA. Aspinwall LG, et al. Among authors: taber jm. Genet Med. 2014 Nov;16(11):846-53. doi: 10.1038/gim.2014.37. Epub 2014 Apr 24. Genet Med. 2014. PMID: 24763292 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page